Perakizumab (RG4934), a humanized IgG1kappa monoclonal antibody targeting IL-17A (Interleukin Related), is utilized in the study of autoimmune conditions, including psoriatic arthritis [1].
Molecular Weight:
145.4 (kDa)
CAS Number:
[89957-37-9]
* VAT and and shipping costs not included. Errors and price changes excepted